HLB Therapeutics Co.,Ltd. (KOSDAQ: 115450)
South Korea
· Delayed Price · Currency is KRW
8,770.00
-70.00 (-0.79%)
Sep 11, 2024, 9:00 AM KST
HLB Therapeutics Co.,Ltd. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 699,994 | 331,362 | 365,136 | 378,914 | 776,711 | 773,154 | |
Market Cap Growth | 46.23% | -9.25% | -3.64% | -51.22% | 0.46% | 13.38% | |
Enterprise Value | 701,342 | 315,400 | 359,858 | 380,861 | 785,426 | 791,163 | |
Last Close Price | 8770.00 | 4385.00 | 5410.63 | 6604.59 | 13629.26 | 14609.44 | |
PE Ratio | - | -136.48 | -30.88 | -22.45 | -43.95 | -46.34 | |
PS Ratio | 10.73 | 6.16 | 8.61 | 8.69 | 18.09 | 13.11 | |
PB Ratio | 4.67 | 1.93 | 2.85 | 2.91 | 7.74 | 10.16 | |
P/FCF Ratio | -185.64 | 109.54 | -29.92 | -31.34 | -66.18 | -126.77 | |
P/OCF Ratio | -207.31 | 99.60 | -41.45 | -33.63 | -66.67 | -139.48 | |
EV/Sales Ratio | 11.63 | 5.87 | 8.49 | 8.74 | 18.30 | 13.42 | |
EV/EBITDA Ratio | -249.08 | -868.53 | -61.61 | -40.58 | -74.33 | -70.67 | |
EV/EBIT Ratio | -52.05 | -35.67 | -47.94 | -34.35 | -69.71 | -66.58 | |
EV/FCF Ratio | -234.98 | 104.26 | -29.49 | -31.50 | -66.92 | -129.72 | |
Debt / Equity Ratio | 0.14 | 0.06 | 0.41 | 0.39 | 0.13 | 0.64 | |
Debt / FCF Ratio | -8.29 | 3.31 | -4.27 | -4.23 | -1.14 | -8.00 | |
Asset Turnover | 0.29 | 0.28 | 0.22 | 0.28 | 0.33 | 0.48 | |
Inventory Turnover | 9.65 | 7.88 | 7.65 | 13.82 | 11.14 | 14.01 | |
Quick Ratio | 2.88 | 1.57 | 1.24 | 1.91 | 1.82 | 0.94 | |
Current Ratio | 3.58 | 1.86 | 1.36 | 2.00 | 2.06 | 1.03 | |
Return on Equity (ROE) | -15.72% | -1.85% | -8.97% | -15.42% | -19.73% | -21.24% | |
Return on Assets (ROA) | -3.11% | -2.85% | -2.49% | -4.45% | -5.39% | -6.01% | |
Return on Capital (ROIC) | -3.30% | -3.06% | -2.60% | -4.70% | -5.90% | -6.90% | |
Earnings Yield | -4.22% | -0.69% | -3.11% | -4.54% | -2.18% | -2.12% | |
FCF Yield | -0.43% | 0.91% | -3.34% | -3.19% | -1.51% | -0.79% | |
Buyback Yield / Dilution | -10.57% | -10.59% | -10.86% | -7.26% | -4.63% | -5.32% | |
Total Shareholder Return | -10.57% | -10.59% | -10.86% | -7.26% | -4.63% | -5.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.